cagrilintide calculator
10 mg in 2 mL = 5 mg/mL; 10 units on a U-100 syringe holds 0.5 mg.
Sizes on sale: 5mg, 10mg. Choose a vial, the water and the amount per draw; prices are the lowest current US offers.
price, vial size and certificate correction
Lowest current US offer for this size.
Most 2–15 mg vials hold 3 mL.
From the lot certificate; it replaces the label amount.
Certificates on file for this compound:
- Amino Club 10mg · lot CAG0002 · 2026-07-30: 10.61 mg measured, 99.84% purityCOA
5 mg/mL
10 units holds 0.5 mg
- concentration
- 5 mg/mL
- per unit
- 50 mcg per unit
- full draws per vial
- —
- cost per draw
- —
the working
- 10 mg ÷ 2 mL = 5 mg/mL
If this is a prescription, the dose and volume on your pharmacy label take priority. Ask your pharmacist about any mismatch.
cheapest way to buy it
| vendor | size | price | $/mg | checked | calculate with this vial, or view it |
|---|---|---|---|---|---|
| LA Peptidesfeatured partner | 10mg | $99.99 | $10.00 | 2026-11-03 | view, Cagrilintide 10mg at LA Peptides, opens in a new tab |
| Amino USA | 10mg | $102.00 | $10.20 | 2026-11-06 | view, Cagrilintide 10mg at Amino USA, opens in a new tab |
| Amino USA | 5mg | $57.00 | $11.40 | 2026-11-06 | view, Cagrilintide 5mg at Amino USA, opens in a new tab |
| American Peptides | 10mg | $170.00 | $17.00 | 2026-11-06 | view, Cagrilintide 10mg at American Peptides, opens in a new tab |
In-stock US offers checked in the last 7 days, before shipping. The featured partner is a paid placement and is labelled; order here is by price per mg.
human trials · cited sources
doses of Cagrilintide used in research
Investigational long-acting amylin analogue, not approved on its own; phase 3 REDEFINE 1 tested 2.4 mg once weekly alone and with semaglutide 2.4 mg (CagriSema, filed with the FDA in December 2025; no approval found as of 2026-11-04). These are the amounts specific labels and studies used, linked to each source. They are references, not recommendations; a prescription label takes priority.
| source | who | amount and schedule | route |
|---|---|---|---|
| Phase 3 REDEFINE 1 (NEJM 2025): cagrilintide 2.4 mg weekly monotherapy arm phase 3 trial · 2025 · PMID 40544433 | Adults without diabetes with BMI 30 or higher (or 27 or higher with an obesity-related complication); 302 assigned to cagrilintide alone out of 3,417 randomized 21:3:3:7 | 2.4 mg once weekly 68 weeks (16-week escalation, then 52-week maintenance) This arm received cagrilintide 2.4 mg with a placebo matched to semaglutide. The 16-week escalation is stated in registry NCT05567796; the step doses are not given there. | subcutaneous |
| Phase 3 REDEFINE 1 (NEJM 2025): cagrilintide 2.4 mg + semaglutide 2.4 mg weekly (CagriSema) phase 3 trial · 2025 · PMID 40544433 | Adults without diabetes with BMI 30 or higher (or 27 or higher with an obesity-related complication); 2,108 assigned to the combination | 2.4 mg once weekly 68 weeks (16-week escalation, then 52-week maintenance) The amount is cagrilintide only, given with semaglutide 2.4 mg weekly. Mean body-weight change at week 68 was -20.4% vs -3.0% with placebo. This is a cagrilintide-semaglutide combination, not a retatrutide blend. | subcutaneous |
| Phase 2 dose-finding (Lancet 2021): 2.4 mg weekly arm phase 2 trial · 2021 · PMID 34798060 | 706 adults without diabetes with BMI 30 or higher (or 27 or higher with hypertension or dyslipidaemia), across all arms | 0.6 mg → 1.2 mg → 2.4 mg once weekly 26 weeks Arms were 0.3, 0.6, 1.2, 2.4 and 4.5 mg weekly, with liraglutide 3.0 mg daily as the active comparator. Escalation was every other week, per posted results of NCT03856047; the 4.5 mg arm took a further step to 4.5 mg at week 6. | subcutaneous |
Sources checked Nov 4, 2026.
Cagrilintide 10mg in 2 mL
amount to syringe units
| amount | mL | U-100 units | U-40 units |
|---|---|---|---|
| 100 mcg | 0.02 | 2 | 0.8 |
| 250 mcg | 0.05 | 5 | 2 |
| 500 mcg | 0.1 | 10 | 4 |
| 1 mg | 0.2 | 20 | 8 |
| 2 mg | 0.4 | 40 | 16 |
| 2.5 mg | 0.5 | 50 | 20 |
| 5 mg | 1 | 100 | 40 |
One unit on a U-100 syringe is 0.01 mL; on a U-40 it is 0.025 mL.
every Cagrilintide vial size on sale
reconstitution chart
| vial | 1 mL water | 2 mL water | 3 mL water | 5 mL water |
|---|---|---|---|---|
| 5 mg | 5 mg/mL 10 units = 0.5 mg | 2.5 mg/mL 10 units = 0.25 mg | 1.667 mg/mL 10 units = 0.167 mg | 1 mg/mL 10 units = 0.1 mg |
| 10 mg | 10 mg/mL 10 units = 1 mg | 5 mg/mL 10 units = 0.5 mg | 3.333 mg/mL 10 units = 0.333 mg | 2 mg/mL 10 units = 0.2 mg |
10 units on a U-100 syringe is 0.1 mL. Every cell is exact arithmetic: amount ÷ water.
what the numbers mean · where they come from
terms and sources
- Label amount or measured amount. The calculator starts from the amount printed on the vial. A lot certificate’s measured content (net peptide content, in mg) can replace it for the vial that was tested. HPLC purity is a share of peak area, not a mass, so a purity-only correction is shown as an estimate. See HPLC, certificate of analysis and how to read a peptide COA.
- Concentration. Amount in the vial ÷ water added. Terms: reconstitution, bacteriostatic water, lyophilized.
- Syringe units. A volume: 0.01 mL per unit on a U-100 syringe, 0.025 mL on U-40. Units say nothing about the compound until the concentration is known.
- Cost per draw. Vial price × amount per draw ÷ vial amount, from the price per mg of a current offer. Offers come from the Cagrilintide price comparison; certificates from the COA library.
Arithmetic only, on the numbers entered. Amounts from labels or trials are cited references, not recommendations; PeptideTech does not give personal use instructions and does not test products.
short answers
Cagrilintide calculator questions
How much bacteriostatic water do I add to Cagrilintide 10mg?
What changes the calculated concentration?
What doses of Cagrilintide were used in research?
What does Cagrilintide cost per mg?
How much Cagrilintide is really in the vial?
more calculators